Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Nausea or Upset Stomach: Some individuals may experience gastrointestinal discomfort after B12 injections
Adverse effects observed in trials include: Nausea and vomiting particularly during dose escalation Diarrhoea or constipation Decreased appetite Injection site reactions Fatigue and dizziness Gallbladder-related events (including gallstones), consistent with effects observed with other GLP-1based therapies [9] Rare cases of pancreatitis , a risk associated with the GLP-1 receptor agonist class [10] [3] Because retatrutide is not licensed in the UK, the MHRA has not issued specific prescribing or dosing guidance for this compound
For weight loss peptides like semaglutide and tirzepatide, the dosing is very different
The average r factor for females is 0.66 , compared to 0.73 for males
